Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
SLC2A9-Mediated Uric Acid Homeostasis Modulates Apoptosis in TNBC
Breast Cancer Targets and Therapy
2026
Chen P.
Open Access
Drug Repurposing and Molecular Insights in the Fight Against Breast Cancer
Biomedical and Pharmacology Journal
June 2024
Jakhmola-Mani R.
Open Access
Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges
Biomedicine and Pharmacotherapy
January 2022
Malik J.A.
Open Access
A combined bioinformatic and nanoparticle-based study reveal the role of abcg2 in the drug resistant breast cancer
Recent Patents on Anti Cancer Drug Discovery
August 2021
Huo Q.
Pharmacodynamic mechanisms of anti-inflammatory drugs on the chemosensitization of multidrug-resistant cancers and the pharmacogenetics effectiveness
Inflammopharmacology
February 2021
Gholamian Dehkordi N.
Evaluation the interaction of ABC multidrug transporter MDR1 with thymoquinone: substrate or inhibitor?
Iranian Journal of Basic Medical Sciences
October 2020
Keyvani V.
Drug-resistance in rheumatoid arthritis: the role of p53 gene mutations, ABC family transporters and personal factors
Current Opinion in Pharmacology
October 2020
Zhang K.X.
Crocin increases gastric cancer cells' sensitivity to doxorubicin
Asian Pacific Journal of Cancer Prevention
July 2020
Razavi S.M.S.
Open Access
Inflammatory pathway interactions and cancer multidrug resistance regulation
Life Sciences
15 October 2019
Mirzaei S.A.
Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia
Materials Science and Engineering C
October 2019
Üner M.
ABCG2 aptamer selectively delivers doxorubicin to drug-resistant breast cancer cells
Journal of Biosciences
1 June 2019
Hashemitabar S.
Expression of oncoprotein gankyrin in drug resistant and sensitive cancer ovarian and gastric cancer cell lines
Journal of Mazandaran University of Medical Sciences
June 2018
Taheri M.
Ionic liquid-assisted synthesis of celexocib using tris-(2-hydroxyethyl) ammonium acetate as an efficient and reusable catalyst
Iranian Journal of Pharmaceutical Research
Winter 2017
Ahfad-Hosseini H.R.
Unexpected lower expression of oncoprotein Gankyrin in drug resistant ABCG2 overexpressing breast cancer cell lines
Asian Pacific Journal of Cancer Prevention
1 December 2017
Taheri M.
NSAIDs induced regulation of alternatively spliced transcript isoforms: Possible role in cancer and alzheimer disease
Current Cancer Drug Targets
2017
Husain M.A.
Alterations in ACE and ABCG2 expression levels in the testes of rats subjected to atropine-induced toxicity
Molecular Medicine Reports
December 2016
Li X.
Open Access
MiR 221/222 as new players in tamoxifen resistance
Current Pharmaceutical Design
1 December 2016
Alamolhodaei N.S.
ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer
Journal of Biosciences
1 June 2016
Hasanabady M.H.
Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-Glycoprotein (Pgp)
Journal of Biological Chemistry
10 April 2015
Jansson P.J.
Open Access
Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients: A Double-Blind, Placebo-Controlled, Randomized Trial
Annals of Pharmacotherapy
September 2015
Mohammadinejad P.